A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty

NCT07710430 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Precocious Puberty

Interventions

DRUG: Leuprorelin

Sponsor

LG Chem